It’s a day we’ve waited for: Moderna is applying for Food and Drug Administration emergency use authorization for its coronavirus vaccine.
Going forward, Mr. Azar wrote in a Sept. 15 memorandum obtained by The New York Times, such power “is reserved to the Secretary.”
FDA Commissioner Stephen Hahn is already backtracking on his comments that convalescent blood plasma is a “breakthrough” treatment for COVID-19.
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
Only in Trump's America would three unserious buffoons try and force the Federal Drug Administration to grant another emergency authorization for an unproven and debunked anti-malaria drug.
In the first weeks of the COVID-19 epidemic in the United States, a shocking breakdown in quality control at the CDC’s central laboratory in Atlanta led to cross-contamination of test materials that made the first round of tests shipped out around the country worthless.
Fox's Laura Ingraham continues to put her viewers' health at risk pushing hydroxychloroquine to combat coronavirus.
"When you do that, we can very substantially lower the cost of prescription drugs on Day One," Sanders said.
When it comes to canines, Donald Trump is bizarrely ignorant—and strangely obsessed
Because apparently it's our job to enforce Big Pharma's national monopolies worldwide.
- 1 of 5